Syra Health Corp. Class A Common Stock (SYRA) - Net Assets
Based on the latest financial reports, Syra Health Corp. Class A Common Stock (SYRA) has net assets worth $2.36 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.94 Million) and total liabilities ($1.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Syra Health Corp. Class A Common Stock (SYRA) cash conversion ratio to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.36 Million |
| % of Total Assets | 59.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 232.33 |
Syra Health Corp. Class A Common Stock - Net Assets Trend (2020–2025)
This chart illustrates how Syra Health Corp. Class A Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore SYRA total assets for the complete picture of this company's asset base.
Annual Net Assets for Syra Health Corp. Class A Common Stock (2020–2025)
The table below shows the annual net assets of Syra Health Corp. Class A Common Stock from 2020 to 2025. For live valuation and market cap data, see Syra Health Corp. Class A Common Stock (SYRA) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $2.10 Million | -27.11% |
| 2024-12-31 | $2.88 Million | -28.27% |
| 2023-12-31 | $4.01 Million | +465.16% |
| 2022-12-31 | $710.10K | +10035.61% |
| 2021-12-31 | $-7.15K | -71.51% |
| 2020-12-31 | $-4.17K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Syra Health Corp. Class A Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 971535900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.54K | 0.60% |
| Other Components | $11.81 Million | 562.69% |
| Total Equity | $2.10 Million | 100.00% |
Syra Health Corp. Class A Common Stock Competitors by Market Cap
The table below lists competitors of Syra Health Corp. Class A Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GEOTRANS S.A. ZY -10
F:5Z4
|
$5.53 Million |
|
Can Fite Biopharma Ltd
TA:CANF
|
$5.54 Million |
|
Versus Systems Inc
NASDAQ:VS
|
$5.54 Million |
|
Starhedge SA
WAR:SHG
|
$5.55 Million |
|
Tambourah Metals Ltd
AU:TMB
|
$5.52 Million |
|
Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
NASDAQ:AZI
|
$5.52 Million |
|
Nippon Active Value Fund Plc
LSE:NAVF
|
$5.52 Million |
|
Beauce Gold Fields Inc
V:BGF
|
$5.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Syra Health Corp. Class A Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,878,571 to 2,098,178, a change of -780,393 (-27.1%).
- Net loss of 896,333 reduced equity.
- New share issuances of 14,800 increased equity.
- Other factors increased equity by 101,140.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-896.33K | -42.72% |
| Share Issuances | $14.80K | +0.71% |
| Other Changes | $101.14K | +4.82% |
| Total Change | $- | -27.11% |
Book Value vs Market Value Analysis
This analysis compares Syra Health Corp. Class A Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.75x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $0.49 | x |
| 2021-12-31 | $0.00 | $0.49 | x |
| 2022-12-31 | $0.10 | $0.49 | x |
| 2023-12-31 | $0.82 | $0.49 | x |
| 2024-12-31 | $0.40 | $0.49 | x |
| 2025-12-31 | $0.18 | $0.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Syra Health Corp. Class A Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -42.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.40%
- • Asset Turnover: 2.61x
- • Equity Multiplier: 1.32x
- Recent ROE (-42.72%) is above the historical average (-90.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.85K |
| 2021 | 0.00% | -0.23% | 2.63x | 0.00x | $-2.57K |
| 2022 | -298.29% | -37.71% | 2.42x | 3.27x | $-2.19 Million |
| 2023 | -73.22% | -53.28% | 1.12x | 1.23x | $-3.34 Million |
| 2024 | -130.59% | -47.10% | 2.17x | 1.28x | $-4.05 Million |
| 2025 | -42.72% | -12.40% | 2.61x | 1.32x | $-1.11 Million |
Industry Comparison
This section compares Syra Health Corp. Class A Common Stock's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $361,876,117
- Average return on equity (ROE) among peers: 9067.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Syra Health Corp. Class A Common Stock (SYRA) | $2.36 Million | 0.00% | 0.67x | $5.52 Million |
| Acadia Healthcare Company Inc (ACHC) | $96.36 Million | -36.21% | 3.29x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $970.49 Million | 7.58% | 0.46x | $1.74 Billion |
| agilon health Inc (AGL) | $661.02 Million | -39.73% | 1.63x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $120.39 Million | -1.84% | 0.42x | $272.31 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $170.84 Million | -71.51% | 1.28x | $624.22 Million |
| American Shared Hospital Service (AMS) | $24.05 Million | -1.30% | 1.98x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $24.17K | 90834.23% | 1.03x | $292.48 Million |
| Ardent Health Partners, Inc. (ARDT) | $760.28 Million | -4.69% | 2.12x | $1.35 Billion |
| Astrana Health Inc (ASTH) | $361.06 Million | 3.91% | 1.02x | $2.15 Billion |
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence ind… Read more